13F Pro

SEC Form 4 reporting owner

Patel Naimish

Patel Naimish has filed 9 Form 4 transactions reported between April 3, 2025 and September 11, 2026, as Director of AgomAb Therapeutics NV and Chief Medical Officer of CRISPR Therapeutics AG.

Name as filed: Patel Naimish

Open-market buys, 24 mo
$50K
1 lines
Open-market sales, 24 mo
$363K
2 lines
Companies
2
with Form 4 filings
Latest transaction
Sep 11, 2026
transaction date

Roles and reported holdings

  • AGMBAgomAb Therapeutics NV
    Sep 11, 2026

    Director

    No common-stock holding reported on a purchase, sale, gift or withholding line.

  • CRSPCRISPR Therapeutics AG
    Apr 3, 2025 – May 29, 2026

    Chief Medical Officer

    Held directly19,357 sh as of May 29, 2026 · Form 4

    24 months: $50K bought · $363K sold

Transaction history

All 9 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 11, 2026AGMBDirectorGrant or awardCode A · direct56,328—Form 4
May 29, 2026CRSPChief Medical OfficerOpen-market saleCode S · direct3,786$211K@ $55.62Form 4
May 29, 2026CRSPChief Medical OfficerGrant or awardCode A · direct22,000—Form 4
May 28, 2026CRSPChief Medical OfficerOption exerciseCode M · direct10,000—Form 4
Mar 20, 2026CRSPChief Medical OfficerGrant or awardCode A · direct30,000—Form 4
Mar 20, 2026CRSPChief Medical OfficerGrant or awardCode A · direct38,499—Form 4
Mar 16, 2026CRSPChief Medical OfficerOpen-market saleCode S · direct3,150$152K@ $48.26Form 4
Mar 14, 2026CRSPChief Medical OfficerOption exerciseCode M · direct8,125—Form 4
Apr 3, 2025CRSPChief Medical OfficerOpen-market purchaseCode P · direct1,508$50K@ $32.96Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.